Jennifer Hellawell, MD, FACC, currently serves as a Board Member for Ohlhoff Recovery Programs and holds the position of Vice President of Clinical Development at Arrowhead Pharmaceuticals. Since March 2017, Jennifer has been an Assistant Clinical Professor of Medicine at UCSF Medical Center. Previous roles include Medical Director of Early Development Cardiometabolic at Amgen and Senior Director of Clinical Development at Eidos Therapeutics. Jennifer has also contributed to the American Heart Association as a Board Member and has extensive experience in cardiovascular medicine, including a fellowship at Boston Medical Center. Educational qualifications include an MD from Joan & Sanford I. Weill Medical College of Cornell University, a Program in Clinical Effectiveness from Harvard T.H. Chan School of Public Health, a certificate in Chinese American Studies from the Hopkins-Nanjing Center, and a Bachelor's degree in Development Economics and Asian Studies from Georgetown University.
This person is not in any teams
This person is not in any offices